Literature DB >> 23255183

Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design.

Jenny Z Zhang1, Paul Bonnitcha, Ezequiel Wexselblatt, Alice V Klein, Yousef Najajreh, Dan Gibson, Trevor W Hambley.   

Abstract

Facile strategies were developed for the versatile functionalization of platinum(IV) axial sites, allowing for easy accessibility to unsymmetric mono- and mixed-carboxylato, as well as symmetric di-substituted platinum(IV) complexes. The first method involves the direct oxidation and carboxylation of the platinum(II) center using an appropriate peroxide and the carboxylate of choice to firstly yield a monocarboxylato monohydroxido platinum(IV) complex. This platinum(IV) intermediate can undergo further carboxylation to give rise to a mixed-carboxylato platinum(IV) complex. The second method involves the activation of the carboxylate of choice by a common carbodiimide coupling reagent, and its reaction with a dihydroxido platinum(IV) precursor to give the monocarboxylato platinum(IV) complex. Uronium salts can be employed to promote efficient dicarboxylation of the dihydroxido platinum(IV) precursor. Lastly, an axial azide pendant group was demonstrated to be suitable for orthogonal "click" conjugation reactions.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255183     DOI: 10.1002/chem.201203159

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  19 in total

Review 1.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

2.  Light-activated protein inhibition through photoinduced electron transfer of a ruthenium(II)-cobalt(III) bimetallic complex.

Authors:  Robert J Holbrook; David J Weinberg; Mark D Peterson; Emily A Weiss; Thomas J Meade
Journal:  J Am Chem Soc       Date:  2015-03-02       Impact factor: 15.419

Review 3.  Transporter and protease mediated delivery of platinum complexes for precision oncology.

Authors:  Trevor W Hambley
Journal:  J Biol Inorg Chem       Date:  2019-05-15       Impact factor: 3.358

4.  Copper-free click-chemistry platform to functionalize cisplatin prodrugs.

Authors:  Rakesh K Pathak; Christopher D McNitt; Vladimir V Popik; Shanta Dhar
Journal:  Chemistry       Date:  2014-04-23       Impact factor: 5.236

5.  The Crystal Structure of Oxaliplatin: A Case of Overlooked Pseudo Symmetry.

Authors:  Timothy C Johnstone
Journal:  Polyhedron       Date:  2014-01-08       Impact factor: 3.052

6.  Synthesis and characterization of Pt(IV) fluorescein conjugates to investigate Pt(IV) intracellular transformations.

Authors:  Ying Song; Kogularamanan Suntharalingam; Jessica S Yeung; Maksim Royzen; Stephen J Lippard
Journal:  Bioconjug Chem       Date:  2013-09-10       Impact factor: 4.774

Review 7.  The Platin-X series: activation, targeting, and delivery.

Authors:  Uttara Basu; Bhabatosh Banik; Ru Wen; Rakesh K Pathak; Shanta Dhar
Journal:  Dalton Trans       Date:  2016-08-16       Impact factor: 4.390

8.  Monofunctional and higher-valent platinum anticancer agents.

Authors:  Timothy C Johnstone; Justin J Wilson; Stephen J Lippard
Journal:  Inorg Chem       Date:  2013-06-05       Impact factor: 5.165

9.  Intratumoral Cancer Chemotherapy with a Carrier-Based Immunogenic Cell-Death Eliciting Platinum (IV) Agent.

Authors:  Chad Groer; Ti Zhang; Ruolin Lu; Shuang Cai; Derek Mull; Aric Huang; Melanie Forrest; Cory Berkland; Daniel Aires; Marcus Laird Forrest
Journal:  Mol Pharm       Date:  2020-10-08       Impact factor: 4.939

10.  A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.

Authors:  Hristo P Varbanov; Simone Göschl; Petra Heffeter; Sarah Theiner; Alexander Roller; Frank Jensen; Michael A Jakupec; Walter Berger; Mathea Sophia Galanski; Bernhard K Keppler
Journal:  J Med Chem       Date:  2014-07-30       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.